Company: INDP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023333
Chunk: 95

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 1
Chunk 95
---
 #
    Furnished
    herewith

10

SIGNATURES

Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report
to be signed on its behalf by the undersigned, thereunto duly authorized.

    Indaptus
    Therapeutics, Inc.

    Date:
    August 13, 2025
    By:
    /s/
    Jeffrey A. Meckler

    Jeffrey
    A. Meckler

    Chief
                                            Executive Officer
    (Principal
    Executive Officer)

    Date:
    August 13, 2025
    By:
    /s/
    Nir Sassi

    Nir
    Sassi

    Chief
                                            Financial Officer
    (Principal
    Financial and Accounting Officer)

11